Proteotech Inc.

Protamed, Inc.

Luke A Esposito

Alan D Snow

Joel Cummings

Thomas P Lake

F Michael Hudson

Manfred Weigele

Marisa C Yadon

Qubai Hu

Lesley Larsen

Judy Cam

Anil M Kumar

Franz F Hefti

Geoffrey Golding

Seok-Rye Choi

Ximin Li

Kelsey Hanson

Anil Kumar

Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.

Compounds for the treatment of neurodegenerative diseases

Compounds and their pharmaceutically acceptable salts for treatment of &#x3b2;-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.

Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies

Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

Compounds, compositions, and methods for the treatment of &#x3b2;-amyloid diseases and synucleinopathies

Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.

Dihydroxyaryl compounds and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of &#x3b2;-amyloid diseases, such as observed in Alzheimer's disease, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies

Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.

Compounds, compositions, and methods for the treatment of synucleinopathies

Growing community of inventors

Seattle, WA, United States of America

Luke A Esposito